mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.07 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.07 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.08 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.08 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.08 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.09 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.09 |